Search Results

Your search for William T. Curry, Jr, MD matches 2 pages

Showing 1 - 2

By William T. Curry, MD / December 15, 2013

Valganciclovir in Glioblastoma, Selection Bias, and Flawed Conclusions

As reviewed in this issue of The ASCO Post, Söderberg-Nauclér et al from the Karolinska Institute have written a provocative letter to The New England Journal of Medicine suggesting that long-term administration of valganciclovir (Valcyte), a drug that targets cytomegalovirus (CMV), improves...

cns cancers

By William T. Curry, Jr, MD / May 15, 2014

Surgical Resection of Newly Diagnosed Glioblastoma: What Is the Standard of Care?

The neurosurgeon is often the gateway provider when patients present with what on magnetic resonance imaging (MRI) appears to be a new glioblastoma. Because histology-based diagnosis is a prerequisite for initiating standard therapy with radiation and chemotherapy, the first question that the...

Apr

Today In Oncology

Search Results

Your search for William T. Curry, Jr, MD matches 2 pages

Valganciclovir in Glioblastoma, Selection Bias, and Flawed Conclusions

Surgical Resection of Newly Diagnosed Glioblastoma: What Is the Standard of Care?

Combined ICI and VEGF Inhibitor Trials in Cancer Cardiovascular Eligibility Criteria and Adverse Event Reporting

Risk of T-Cell and Second Primary Malignant Neoplasms After CAR T-Cell Therapy

Lack of Research Focused on Older Adults With Cancer May Be Contributing to Disparities in Care

Breast Cancer Survivors: Relationship Satisfaction and Emotional and Physical Well-Being

FDA Approves Lu-177 Dotatate for Pediatric Patients With GEP-NETs